Email
Password
Remember meForgot password?
    Log in with Twitter

Pharmaceuticals News

U.S. science center withdraw from sterile products manufacturing

Washington - The U.S. public-sector science base, the National Institutes of Health (NIH), has announced it will suspend all research related to sterile medicinal products after the test areas were found to be out of compliance with good practices.

Mixed news for Novartis

Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.

New leukemia and Zika drugs in the pipeline

Two very different drugs are making progress in news announced this week. The FDA has approved a new leukemia medication, and work is progressing on a Zika virus treatment.

Weekly pharmaceutical news roundup

This week has seen progress updates issued for new drug products for rheumatoid arthritis, skin dermatitis, and for hepatitis. Each of the products is at the clinical trial stage, and three of the drugs on offer are the result of partnerships.

Head of GSK to retire, and other pharma news

The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.

List of largest medical fines revealed

The last couple of years have seen a slight lowering in the number of cases brought against medical companies; however, at the same time, there was an increase in the level of fines paid out.

Pharmaceutical sector round-up: Legal action dominates

As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.

Belgian pharma bosses 'accused of selling to Mexican drug baron'

Brussels - Belgian federal prosecutors are seeking to bring to court seven pharmaceutical executives accused of supplying a Mexican drug baron with the key ingredients for crystal meth, they said Wednesday.

India’s Ipca Laboratories receives FDA warning

Mumbai - The U.S. Food and Drug Administration has issued a warning notice to Ipca Laboratories, which is based in India, for data integrity issues.

Big Pharma wants governments to pay for new antibiotics

Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?

Johnson and Johnson hit by shares drop

U.S. healthcare colossus Johnson and Johnson saw a drop in its share value by 6 percent during 2015, according to the company’s latest financial statement.

FDA takes legal action against pharmaceutical company

Washington - A consent decree has been opened against Downing Labs LLC, of Dallas, Texas, together with the holding company. The action has been initiated by U.S. District Judge Sam A. Lindsay.

Major pharmaceutical companies announce big layoffs

We are only into the early days of 2016 but this hasn’t slowed the actions of companies doing anything to protect their share prices. Two big pharmaceutical companies have already announced plant closures and layoffs.

Most clinical trials today are funded by Big Pharma

Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.

Pharmaceutical boss arrested in securities fraud

The former, and controversial, CEO of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., Martin Shkreli, has been detained for securities fraud.

Global drug spending set to rise to $1.4 trillion

In news that will no doubt please the shareholders of pharmaceutical companies, the global spend on drug products is set to rise by 30 percent by the year 2020. This means an annual pay-out of $1.4 trillion.

Many pharma companies failing the clinical trials test

London - The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.

FDA blocks imports from Megafine Pharma

The U.S. Food and Drug Administration (FDA) has placed an import ban on the drug maker Megafine Pharma's Nashik site in Maharashtra, India.

Time to get clean on pharma pollution?

Most countries do not have any legal limits for the control of pollution from drugs during their manufacture, use and disposal. Some people are now calling for urgent action.

Has Turing Pharmaceuticals violated antitrust rules?

An investigation has been initiated in New York to see whether Turing Pharmaceuticals has contravened antitrust rules by restricting distribution of the drug Daraprim, as a means to block generic competition.

Roche in $580 pharma acquisition

Swiss drug giant Roche is to acquire rival company Adheron Therapeutics for $580 million. Adheron Therapeutics are based in the U.S.

Pharma company criticized over pigeons in process area

Mumbai - Pan Drugs Limited of Nandesari, India has been cited by the U.S. FDA for evidence of pigeons in an area of a drug manufacturing facility used to process medications.

Polydrug Laboratories banned from importing to U.S.

Mumbai - The company Polydrug Laboratories is no longer able to import medicinal products into the U.S. following a series of concerns about manufacturing standards.

Research companies pair up to tackle antibiotic resistance

London - As part of the growing action against the progressive rise in antibiotic resistant bacteria, two R&D organizations are to work together with the aim of creating new antibiotics.

Op-Ed: Global drug imports from India need better standards

Mumbai - The Indian pharmaceutical sector is beset with compliance problems. This is demonstrated via a series of import bans into the U.S. imposed by the U.S. Food and Drug Administration (FDA).

Pharmaceutical industry news round-up

Digital Journal delves into the key pharmaceutical sector business news. This week we bring updates from Novartis, Bayer, Boehringer and Lilly.

Amgen fined in the U.S. over 'improper advertising'

The pharmaceutical company Amgen has been fined by U.S. authorities in relation to the advertising of its products. The settlement is $71 million.

Is pharmaceutical waste triggering antibiotic resistance?

Several pharmaceutical companies have been accused by a campaign organization of contributing to the rise of antibiotic resistance among types of pathogenic bacteria, the so-termed "super bugs."

Big Pharma: Teva bids $40 billion for Mylan

Israel-based pharmaceutical company Teva makes an unsolicited offer for a smaller, Netherlands-based rival called Mylan, as its main product faces competition from generics.

AbbVie in major pharma acquisition

The pharmaceutical company AbbVie beat out a range of other major pharmaceutical firms, including global giant Johnson & Johnson, to reach a $21 billion deal with cancer drug specialist Pharmacyclics.
  1 2 3 Next»

Set up a news alert for

Pharmaceuticals


Pharmaceuticals Image

Medicine vials on display at making Pharmaceuticals 2015.
Medicine vials on display at making Pharmaceuticals 2015.
A variety of statin drugs
A variety of statin drugs
Dr. Olumayokun Olajide s research will now look to produce compound derivatives of punicalagin for a...
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's
University of Huddersfield
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
Alexion Pharmaceuticals
Untitled
Grumpy-Puddin
Project Team at work:  Expertise helps AbbVie develop and enhance products and therapies to treat co...
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer.
© AbbVie Inc.
Eli Lilly s global headquarters  Indianapolis  Indiana
Eli Lilly's global headquarters, Indianapolis, Indiana
Guanaco152003
Sativex contains marijuana-derived ingredients.
Sativex contains marijuana-derived ingredients.
Associated Press
Biogen is an American global biotechnology company based in Cambridge  Massachusetts  specializing i...
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Biogen

Latest News
Top News